ARMC5 controls the degradation of most Pol II subunits, and ARMC5 mutation increases neural tube defect risks in mice and humans
Hongyu Luo(Hebei Medical University), Jiangping Wu(Huazhong University of Science and Technology)
Cited by 14
Related Papers
EphB6 crosslinking results in costimulation of T cells
|Journal of Clinical Investigation|2002|74
EphB6 crosslinking results in costimulation of T cells
|Journal of Clinical Investigation|2002|64
Armc5 deletion causes developmental defects and compromises T-cell immune responses
|Nature Communications|2017|62
Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor‐Infiltrating Lymphocytes: A Cohort Study
|Journal of Immunology Research|2020|56
The role of TGFBI (βig-H3) in gastrointestinal tract tumorigenesis
|Molecular Cancer|2015|51